Matthew Hawryluk

Matthew Hawryluk serves as the Chief Business Officer at AIRNA since January 2025 and is a Director on the Board of Directors for both OUROTECH, INC. and Predictive Oncology. Previously, Matthew held several key positions at Gritstone bio, including Executive Vice President and Chief Business Officer, where notable achievements included leading significant agreements for COVID-19 vaccine trials and collaborations with major biotech firms. Additional experience encompasses advisory roles and leadership in corporate and business development at companies such as PathAI and Foundation Medicine. Matthew's educational background includes a PhD in Cell Biology and Biochemistry from the University of Pittsburgh School of Medicine, an MBA from Carnegie Mellon University's Tepper School of Business, and a BS in Biochemistry from the University of Notre Dame.